CROSSTALK IN GBMS

GENOMIC AND TRANSCRIPTIONAL ANALYSIS OF GLIOBLASTOMA MICROENVIRONMENTAL CELLULAR SUBSETS USING ANTIBODY MICROARRAYS

 Coordinatore UNIVERSITA DEGLI STUDI DI VERONA 

 Organization address address: VIA DELL ARTIGLIERE 8
city: VERONA
postcode: 37129

contact info
Titolo: Dr.
Nome: Manuela
Cognome: Calderara
Email: send email
Telefono: 390458000000
Fax: 390458000000

 Nazionalità Coordinatore Italy [IT]
 Totale costo 230˙084 €
 EC contributo 230˙084 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-IOF
 Funding Scheme MC-IOF
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-10-01   -   2014-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI VERONA

 Organization address address: VIA DELL ARTIGLIERE 8
city: VERONA
postcode: 37129

contact info
Titolo: Dr.
Nome: Manuela
Cognome: Calderara
Email: send email
Telefono: 390458000000
Fax: 390458000000

IT (VERONA) coordinator 230˙084.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

italy    applicant    transcriptional    genomic    vascular    cells       ucla    deal    cellular    gbms    therapeutic    samples    subtypes    gbm    tumor    cancer   

 Obiettivo del progetto (Objective)

'The applicant is an experienced researcher with the objective of completing comprehensive training in translational research on Glioblastoma Multiforme (GBM), one of the most common malignant and lethal primary brain tumor of adults, with the final aim of disposing of personalized therapeutic protocols for GBM and cancer patients. The project is based on the finding that human tumors, particularly GBMs, are composed of a mixture of cancer, immune, stromal and vascular cells. The non-cancerous cellular components of the tumor microenvironment appear to play a critical role in tumor development and progression. At UCLA (Los Angeles, U.S.A.), the Mischel Lab has developed the DNA Encoded Antibody Library (DEAL) microarray, to sort specific cellular subtypes from solid tumor samples. The selective capture of tumor cells, lymphocytes, microglia and vascular endothelial cells, directly from GBM biopsy samples, will be obtained by DEAL technology. Genomic and transcriptional analysis will be performed on DEAL sorted cellular subtypes in order to identify novel molecular targets for therapeutic intervention. Genomic and transcriptional findings will be validated with functional assays in model systems: oncogene overexpression, gene silencing and pharmacological inhibition will be applied in order to identify the factors that inhibit the growth and survival of GBMs. In the first phase of the fellowship, at UCLA, the applicant will be utilizing cutting edge nanotechnology and resources that will provide her with outstanding interdisciplinary skills and competences. The applicant will then have the professional maturity to transfer her novel knowledge to the University of Verona (Italy), enriching the scientific excellence of Europe and bridging a new set of collaborations between Italy and the U.S.A.'

Altri progetti dello stesso programma (FP7-PEOPLE)

DESSARITH (2012)

Dessins and Arithmetic

Read More  

SPRINT (2014)

Strategic Partnership in Transition

Read More  

CREC (2010)

Coastal Research Network On Environmental Changes

Read More